Join Resmed at the ERS congress 2025 | Resmed

ERS 2025

Join us in Amsterdam, 27 September – 1 October

View our sessions​
Get your free notebook​

Sunday 28 September

Beyond CPAP: Tackling Complex Cases

10:30 to 11:15, Room E 102

SPEAKERS: Sophia Schiza (Greece), Amanda Sathyapala (UK), Holger Woehrle (Germany), Sébastien Baillieul (France).

Discover the latest practical strategies to enhance therapy adherence and tailor treatment for patients with OSA and Emerging Central Sleep Apnoea

Add to calendar - CET time 09/28/2025 10:30 am 09/28/2025 11:15 am >Europe/Paris Resmed > Beyond CPAP: Tackling Complex Cases Beyond CPAP: Tackling Complex Cases

Sunday 28 September
10:30 to 11:15, Room E 102

SPEAKERS:

Sophia Schiza (Greece),
Amanda Sathyapala (UK),
Holger Woerhle (Germany),
Sébastien Baillieul (France).

Discover the latest practical strategies to enhance therapy adherence and tailor treatment for patients with OSA and Emerging Central Sleep Apnoea Room E 102

Monday 29 September

Personalised Non Invasive Ventilation: Unlocking the Value

10:30 to 11:15, Room E 102

SPEAKERS: Marieke Duiverman (Netherlands), Chris Carlin (UK), Maria Jose Guimaraes (Portugal), Ulla Anttalainen (Finland).

Explore practical and digital strategies for initiating, managing, and optimising home ventilation treatment.

Add to calendar - CET time 09/29/2025 10:30 am 09/29/2025 11:15 am >Europe/Paris Resmed > Personalised Non Invasive Ventilation: Unlocking the Value Personalised Non Invasive Ventilation: Unlocking the Value

Monday 29 September - 10:30 to 11:15, Room E 102

SPEAKERS: Marieke Duiverman (Netherlands), Chris Carlin (UK), Maria Jose Guimaraes (Portugal), Ulla Anttalainen (Finland).

Explore practical and digital strategies for initiating, managing, and optimising home ventilation treatment. Room E 102

Your partner in the journey to sleep & breathing health

We’re here to support you and your patients at every step​

Lead with clinical confidence​

You seek trusted clinical solutions – We bring evidence and expertise.​

Benefit from everyday support​

You focus on delivering excellent care – We’re here to make that easier.​

Streamline your care, seamlessly​

You need solutions that work the way you do – We provide scalable, seamless products, built for real-life workflow.​

Personalise through innovation​

You’re striving to deliver more personalised care – We’re helping to make that possible.​

Rely on built-in compliance​

You need solutions you can trust, every day – We invest in quality, privacy and security.​

How can we best support your practice and patients’ needs?

We’re here to support you and your patients at every step.
Tell us what matters most to you and get your free notebook!​

We'd love to know more...
​Select the option that matters most to you and get a free notebook:​​ *

Please answer the question above

Please answer the question above

Please answer the question above

By clicking on “Submit”, you also consent to the processing of your data by Resmed in order to manage your request. For further information about how Resmed processes your personal data, please visit our privacy notice.

Submit
The content is intended for health professionals only.​​

Please refer to the user and clinical guides for relevant information related to any contraindications, warnings and precautions to be considered before and during use of the products.

Disclaimers:​
  • ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.​
  • ReSupply services are available only in certain markets​
  • AirView was built to be secure and compliant with (EU) 2016/679 (General Data Protection Regulation) and national privacy laws. It uses data encryption technologies to secure patient data and is classified as a CE medical product. Resmed obtained dual HDS/ISO 27001 certification for AirView to demonstrate our commitment to secure data processing and hosting and to ensure our teams and systems are operating at the highest standards, as verified by independent auditors.
References​
  1. Pépin et al. Adherence to Positive Airway Therapy After Switching From CPAP to ASV: A Big Data Analysis. J Clin Sleep Med. 2018 Jan 15;14(1):57-63. doi: 10.5664/jcsm.6880​​
  2. Tamisier R et al. Analysis of impact on Pittsburgh sleep quality index in a wide spread of CSA treated with ASV: 6-month follow-up FACIL-VAA study results. ERJ 2022. doi:10.1183/13993003.congress-2022.4688.​
    Arzt M et al. Effects of Adaptive Servo-Ventilation on Quality of Life: The READ-ASV Registry. Ann Am Thorac Soc. 2024 doi:10.1513/AnnalsATS.202310-908OC​
    Tamisier R et al. FACE study: 2-year follow-up of adaptive servo-ventilation for sleep-disordered breathing in a chronic heart failure cohort. Sleep Med. 2024 doi:10.1016/j.sleep.2023.07.014 ​
    Tamisier R et al. Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data. Thorax. 2022 doi:10.1136/thoraxjnl-2021-217205.​
  3. Compared with patients not treated with PAP therapy.​
    Benjafield et al., Positive airway pressure therapy and all‐cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies Lancet Resp Med 2025. ​
  4. Pépin et al. Health trajectories before initiation of non-invasive ventilation for chronic obstructive pulmonary disease: a French nationwide database analysis, The Lancet Regional Health – Europe, 2023,100717, ISSN 2666-7762, https://doi.org/10.1016/j.lanepe.2023.100717.​
    Pépin et al. Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models. Thorax Published Online First:19 May 2025. doi:10.1136/thorax-2024-222392.​
  5. Airview support . 94% satisfaction on all AV tickets opening, April-September 2025 period. NPS Survey with case reports 509205. Data on file.​
  6. https://document.resmed.com/documents/uk/10110304r2+Airview+Integration+OS+case+study+EMEA+ENG+LOW.pdf Case study Improving workflow efficiency and patient care with AirView integration​
  7. https://document.resmed.com/documents/uk/1019845+AirView+San+Salvadour+Case+study+EU+ENG+LOW.pdf Case Study Improving collaboration and enabling better patient outcomes through connected care​
  8. Resmed 4Q25 Earnings Presentation, July 2025.
  9. Schuffelen, J., Maurer, L.F., Lorenz, N., Roetger, A., Pietrowsky, R., & Gieselmann, A. (2023). The clinical effects of digital cognitive behavioral therapy for insomnia in a heterogeneous study sample: results from a randomized controlled trial, Sleep, Volume 46, Issue 11, zsad184, https://doi.org/10.1093/sleep/zsad184​
    Maurer, L. F., Aust, F., & Lorenz, N. (2023). Real-world evidence for the use of digital cognitive behavioral therapy for insomnia in standard care. Somnology, 1-9. https://doi.org/10.1007/s11818-023-00422-7​
  10. Pépin et al. ERS 2025 Abstract 54284. Impact of patient engagement tool on PAP therapy outcomes. 72.7% adherence in fully engaged group vs. 60.7% for non-engaged​
  11. Resmed Trust Center https://www.resmed.co.uk/impact/protecting-your-data/trust-center/​
  12. Resmed 2024 Sustainability report. https://document.resmed.com/documents/global/ResMed_Sustainability_report.pdf